Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Patients with transitional cell carcinoma of the bladder classically present with irritative voiding symptoms or painless hematuria. Common sites of vascular metastases include the liver (38%), lung (36%), bone (27%), adrenal glands (21%), and intestine (13%). Vascular metastasis to the brain, without a prior history of chemotherapy, is extremely rare. To our knowledge, this is the first report of a patient with bladder transitional cell carcinoma whose original presentation was from a symptomatic, metastatic, cerebellar lesion.


Journal article



Publication Date





Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Transitional Cell, Cerebellar Ataxia, Cerebellar Neoplasms, Cisplatin, Combined Modality Therapy, Craniotomy, Cystectomy, Doxorubicin, Humans, Male, Methotrexate, Middle Aged, Radiosurgery, Urinary Bladder Neoplasms, Vinblastine